Radiological Description and Impact on Outcome of Postoperative Residue After High-Risk Neuroblastoma Surgery

被引：0
|
作者：
Irtan, S. [1 ]
Le Pointe, H. Ducou [2 ]
Fayard, C. [3 ]
Gabra, H. [4 ]
Granata, C. [5 ]
Avanzini, S. [6 ]
Pio, L. [6 ]
Gomez-Chacon, J. [7 ]
Braungart, S. [8 ]
Stenman, J. [9 ]
Sundquist, F. [9 ]
Stromgren, J. [10 ]
Plantaz, D. [11 ]
Matthyssens, L. [12 ]
Jauquier, N. [13 ]
Bjornland, K. [14 ]
Ingegerd, A. [15 ]
Cross, K. [16 ]
McHugh, K. [17 ]
Sarnacki, S. [18 ]
机构：
[1] Hop Tousseau, AP HP, Pediat Surg, Paris, France
[2] Hop Trousseau, AP HP, Pediat Radiol, Paris, France
[3] Curie Inst, Pediat Radiol, Paris, France
[4] Newcastle Tyne Upon Hosp NHS Fdn Trust, Newcastle, NSW, Australia
[5] Giannina Gaslini Inst, Pediat Radiol, Genoa, Italy
[6] Giannina Gaslini Inst, Pediat Surg, Genoa, Italy
[7] Hosp La Fe, Pediat Surg, Valencia, Spain
[8] Royal Manchester Childrens Hosp, Pediat Surg, Manchester, Lancs, England
[9] Karolinska Univ Hosp, Pediat Surg & Urol, Stockholm, Sweden
[10] Karolinska Univ Hosp, Pediat Radiol, Stockholm, Sweden
[11] CHU Grenoble, Serv Immunohematooncol Pediat, Grenoble, France
[12] Princess Elisabeth Childrens Hosp, Neonatal & Paediat Surg, Ghent, Belgium
[13] CHUV Lausanne, Serv Chirurg Pediat, Lausanne, Switzerland
[14] Oslo Univ Hosp, Pediat Surg, Oslo, Norway
[15] Oslo Univ Hosp, Pediat Radiol, Oslo, Norway
[16] Pediat Surg, Great Ormond St Children, London, England
[17] Great Ormond St Hosp Sick Children, Pediat Radiol, London, England
[18] Hop Necker Enfants Malad, AP HP, Pediat Surg, Paris, France
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-064
引用
收藏
页码：S37 / S38
页数：2
相关论文
共 50 条
  • [41] RNAseq identified immune signatures associated with adverse outcome in high-risk neuroblastoma
    Wei, Jun S.
    Zhang, Shile
    Kuznetsov, Igor
    Song, Young K.
    Asgharzadeh, Shahab
    Sindiri, Sivasish
    Wen, Xinyu
    Patidar, Rajesh
    Auvil, Jaime M. Guidry
    Gerhard, Daniela S.
    Seeger, Robert
    Maris, John M.
    Khan, Javed
    CANCER RESEARCH, 2017, 77
  • [42] The Impact of Gross Total Resection on Survival in Children with High-Risk Neuroblastoma
    Komatsu, Shugo
    Saito, Takeshi
    Terui, Keita
    Nakata, Mitsuyuki
    Harada, Kazuaki
    Shinno, Yoshitaka
    Katsumi, Daisuke
    Furugane, Ryoya
    Yoshida, Hideo
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S39 - S39
  • [43] Genome-based outcome prediction in MYCN nonamplified high-risk neuroblastoma
    La Madrid, Andres Eduardo Morales
    Stricker, Thomas
    Pytel, Peter
    Gosiengfiao, Yasmin C.
    Shohet, Jason
    Shimada, Hiroyuki
    Furman, Wayne Lee
    Zage, Peter E.
    Park, Julie R.
    Perlman, Elizabeth
    Guerrero, Lisa
    Salwen, Helen
    Chlenski, Alexandre
    London, Wendy B.
    Cohn, Susan Lerner
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
    Yanik, Gregory
    Naranjo, Arlene
    Parisi, Marguerite T.
    Shulkin, Barry L.
    Nadel, Helen
    Gelfand, Michael J.
    Ladenstein, Ruth
    Boubaker, Ariane
    Poetschger, Ulrike
    Valteau-Couanet, Dominique
    Kreissman, Susan G.
    Park, Julie R.
    Matthay, Katherine K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S107 - S107
  • [45] Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy
    Yanishevski, David
    McCarville, M. Beth
    Doubrovin, Mikhail
    Spiegl, Hannah R.
    Zhao, Xiwen
    Lu, Zhaohua
    Federico, Sara M.
    Furman, Wayne L.
    Murphy, Andrew J.
    Davidoff, Andrew M.
    JOURNAL OF PEDIATRIC SURGERY, 2020, 55 (01) : 130 - 134
  • [46] TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Hishiki, T.
    Horie, H.
    Higashimoto, Y.
    Yotsumoto, K.
    Komatsu, S.
    Okimoto, Y.
    Kakuda, H.
    Taneyamai, Y.
    Yoshida, H.
    Iwai, J.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S331 - S331
  • [47] The impact of radiological imaging of high-risk cutaneous squamous cell carcinoma
    Drumm, Ciara
    Doyle, Claire
    O'Loughlin, Sarah
    McKay, Hannah
    Moloney, Aoife
    Dolan, Roisin
    Lawlor, Caitriona
    Hellen, Rebecca
    Moriarty, Blaithin
    Lally, Aoife
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (03) : 243 - 244
  • [48] Dinutuximab: A Review in High-Risk Neuroblastoma
    Sheridan M. Hoy
    Targeted Oncology, 2016, 11 : 247 - 253
  • [49] Retinoid therapy of high-risk neuroblastoma
    Reynolds, CP
    Matthay, KK
    Villablanca, JG
    Maurer, BJ
    CANCER LETTERS, 2003, 197 (1-2) : 185 - 192
  • [50] Influence of Sarcopenia in High-risk Neuroblastoma
    Kawakubo, Naonori
    Souzaki, Ryota
    Koga, Yuuki
    Kinoshita, Yoshiaki
    Ohga, Shouichi
    Taguchi, Tomoaki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S43 - S43
12345